Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Challenges and shifting paradigms in clinical trial designs

The value of "early" endpoints (MPR, pCR) in neoadjuvant trials


31 Mar 2023


Challenges and shifting paradigms in clinical trial designs


Tumour Site

Non-Small Cell Lung Cancer


Mariano Provencio Pulla


M. Provencio Pulla

Author affiliations

  • Majadahonda/ES


Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.